Kishor Mandaliya

HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational study

Raph L Hamers, Carole L. Wallis, Cissy Kityo et al. · The Lancet Infectious Diseases · 2011 · 292 citations

Public Health, Pharmacology, Pharmacotherapy +17

Effect of pretreatment HIV-1 drug resistance on immunological, virological, and drug-resistance outcomes of first-line antiretroviral treatment in sub-Saharan Africa: a multicentre cohort study

Raph L Hamers, Rob Schuurman, Kim Sigaloff et al. · The Lancet Infectious Diseases · 2011 · 197 citations

Life Sciences, Infectious Diseases, Microbiology +17

Unnecessary Antiretroviral Treatment Switches and Accumulation of HIV Resistance Mutations; Two Arguments for Viral Load Monitoring in Africa

Kim Sigaloff, Raph L Hamers, Carole L. Wallis et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2011 · 186 citations

Life Sciences, Infectious Diseases, Microbiology +17

Patterns of HIV-1 Drug Resistance After First-Line Antiretroviral Therapy (ART) Failure in 6 Sub-Saharan African Countries: Implications for Second-Line ART Strategies

Raph L Hamers, Kim Sigaloff, Annemarie M. J. Wensing et al. · Clinical Infectious Diseases · 2012 · 161 citations · Full text

Life Sciences, Pharmacology, Antimicrobial Resistance +16

The significance of Lactobacillus crispatus and L. vaginalis for vaginal health and the negative effect of recent sex: a cross-sectional descriptive study across groups of African women

Vicky Jespers, Janneke van de Wijgert, Piet Cools et al. · BMC Infectious Diseases · 2015 · 122 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17